|
|
|
|
|
|
||||||||
|
||||||||
![]() Click here for low bandwidth version |
USD
USD
|
EUR
EUR
|
GBP
GBP
|
Converter
Converter
|
||
|
|
|||||
Gold (INR/Gram)
Gold (INR/Gram)
|
Silver (INR/Kilo)
Silver (INR/Kilo)
|
||||
| LIVE DATA TERMINALS: Nifty50 | IT | Bank | |
|
|
Piramal Healthcare | Piramal Healthcare Limited | Live NSE Share Price Quotes Piramal Healthcare | Realtime Piramal Healthcare Chart |
| LIVE QUOTES - LIST OF ALL NSE STOCKS WITH CURRENT PRICES |
|
more information on Piramal Healthcare Limited from bse
|
|||||||||||||||||||||||||
Piramal Healthcare Limited - 3 Months Candlestick Chart |
|
Vodafone Group Plc May Buy Piramal Healthcare Limited Stake In India Unit If No IPO In About Two Years-DJ
Vodafone Group Plc May Buy Piramal Healthcare Limited Stake In India Unit If No IPO In About Two Years-DJ
Reuters Key Development - 16 hours ago
Piramal Healthcare to Acquire Providence Equity Partners' DRG
Piramal Healthcare to Acquire Providence Equity Partners' DRG
Private Equity Hub (press release) - May 17, 2012 Pharmaceutical manufacturing company Piramal Healthcare is to acquire US-based healthcare information company Decision Resources Group from Providence Equity Partners for around US$635 million.
Piramal Healthcare Limited to Acquire Decision Resources Group
Piramal Healthcare Limited to Acquire Decision Resources Group
MarketWatch (press release) - May 16, 2012 Piramal Healthcare Limited [NSE: PIRHEALTH, BSE: 500302], an innovation led company, has agreed to acquire Decision Resources Group a US based company in the healthcare information segment, from Providence Equity Partners for a consideration of ...
Piramal Healthcare Limited To Acquire Decision Resources Group
Piramal Healthcare Limited To Acquire Decision Resources Group
Reuters Key Development - May 15, 2012
Piramal Healthcare Presents Positive Results of Pivotal Phase III Clinical ...
Piramal Healthcare Presents Positive Results of Pivotal Phase III Clinical ...
PR Newswire (press release) - May 14, 2012 Piramal Healthcare Bio-Orthopaedics, a division of Piramal Healthcare Limited [NSE: PIRHEALTH, BSE: 500302], today announced that positive data from their pivotal (Phase III) clinical trial is being presented in 3 podium presentations as well as during ...
|
|
About Indiansplash.com |
Disclaimer |
Privacy Policy |
Terms of Use |
Advertise |
Sitemap |
Contact Us
|